George W. Lloyd, EVP, Investments & GC at Royalty Pharma plc (RPRX), sold 109,358 shares at $46.34 ($5.1M) on 2021-03-22, disclosed to the SEC on 2021-03-24.
Open-market sale of $5.1M RPRX by EVP, Investments & GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.32 | 43,642 | $2.0M | 39.9% |
| 2 | $46.32 | 43,642 | $2.0M | 39.9% |
| 3 | $46.34 | 10,987 | $509K | 10.1% |
| 4 | $46.34 | 10,987 | $509K | 10.1% |
| 5 | $47.04 | 100 | $5K | 0.1% |
| Total | $46.32 avg | 109,358 |
| $5.1M |
| 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |